Preclinical toxicology studies of recombinant human platelet-derived growth factor-bb either alone or in combination with beta-tricalcium phosphate and type I collagen

Journal of Tissue Engineering

Volumn 1, Issue 1, 2010, Pages 1-8

  Young, Conan S ^a   Bradica, Gino ^b   Hart, Charlie E ^a   Karunanidhi, Anuradha ^c   Street, Reva M ^d   Schutte, Lyndsey ^d   Hollinger, Jeffrey O ^d,e  

^a Advanced BioHealing Inc ^*  (United States)

^b Kensey Nash Corporation   (United States)

^c PA 15260   (United States)

^d CARNEGIE MELLON UNIVERSITY   (United States)

^e CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CELL PROLIFERATION; PLATELETS; SYNTHESIS (CHEMICAL); TISSUE; TOXICITY; TRANSMISSION CONTROL PROTOCOL;

BETA TRICALCIUM PHOSPHATE; BIOLOGICAL EFFECTS; CELL DIVISIONS; DNA SYNTHESISS; GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTORS; TISSUE RESPONSE; TYPE I COLLAGEN; TYPE-I COLLAGEN; Β-TCP;

COLLAGEN;

EID: 84890180457     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.4061/2010/246215     Document Type: Review

References (16)

1. R. Ross, E. W. Raines, and D. F. Bowen-Pope, "The biology of platelet-derived growth factor," Cell, vol. 46, no. 2, pp. 155-169, 1986.
2. E. Canalis, T. L. McCarthy, and M. Centrella, "Effects of platelet-derived growth factor on bone formation in vitro," Journal of Cellular Physiology, vol. 140, no. 3, pp. 530-537, 1989.
3. P. Cassiede, J. E. Dennis, F. Ma, and A. I. Caplan, "Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β1 or PDGF-BB as assayed in vivo and in vitro," Journal of Bone and Mineral Research, vol. 11, no. 9, pp. 1264-1273, 1996.
4. K. K. Hirschi, S. A. Rohovsky, and P. A. D'Amore, "PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate," Journal of Cell Biology, vol. 141, no. 3, pp. 805-814, 1998.
5. K. K. Hirschi, S. A. Rohovsky, L. H. Beck, S. R. Smith, and P. A. D'Amore, "Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact," Circulation Research, vol. 84, no. 3, pp. 298-305, 1999.
6. E. Brogi, T. Wu, A. Namiki, and J. M. Isner, "Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only," Circulation, vol. 90, no. 2, pp. 649-652, 1994.
7. S. E. Lynch, "Bone regeneration techniques in the orofacial region," in Bone Regeneration and Repair: Biology and Clinical Applications, J. R. Lieberman and G. E. Friedlaender, Eds., pp. 359-390, Humana Press, Ottawa, NJ, USA, 2005.
8. D. Matthews, "Synthetic platelet-derived growth factor (rhPDGF) may improve bone fill over beta-tricalcium phosphate (beta-TCP) alone," Journal of Periodontal Research, vol. 76, no. 12, pp. 1-2, 2005.
9. E. V. Knight, J.W. Oldham, M. A. Mohler, S. Liu, and J. Dooley, "A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB)," American Journal of Surgery, vol. 176, no. 2, pp. 55S-60S, 1998.
10. USP 28, "National Formulatory 23. Biological Reactivity Test, In Vivo," 2005.
11. ISO 10993-11, Biological Evaluation of Medical Devices-Part 11: Tests for Systemic Toxicity, International Organization for Standardization, Geneva, Switzerland, 1993.
12. ISO 10993-10, Biological Evaluation of Medical Devices -Part 10: Tests for Irritation and Delayed-Type Sensitivity, International Organization for Standardization, Geneva, Switzerland, 2002.
13. B. Magnusson and A. M. Kligman, "The identification of contact allergens by animal assay. The guinea pig maximization test," Journal of Investigative Dermatology, vol. 52, no. 3, pp. 268-276, 1969.
14. ISO 10993-5, Biological Evaluation of Medical Devices-Part 5: Tests for In Vitro Cytotoxicity, International Organization for Standardization, Geneva, Switzerland, 1999.
15. ISO 10993-3, Biological Evaluation of Medical Devices-Part 3: Tests for Genotoxicity, Carcinogenicity, and Reproductive Toxicology, International Organization for Standardization, Geneva, Switzerland, 2003.
16. ISO 10993-4, Biological Evaluation of Medical Devices-Part 4: Selection of Tests for Interactions with Blood, International Organization for Standardization, Geneva, Switzerland, 2002.